Skip to main content

Orthocell soars 356% on test results

08/05/2019 - 12:24

Bookmark

Save articles for future reference.

Shares in Perth biotech Orthocell more than quadrupled in value today after the company released positive results from a trial of its nerve regeneration product.

X

To read our articles you will need to either login or subscribe.